Lexicon Pharmaceuticals.
biopharmaceutical company
- Reports this week
- 0
- Active events
- 0
- Connections
- 37
What's happening
Earlier this month
One to three months ago
Gone quiet
No new reports in 90+ days-
Citigroup raised its rating on the stock of Lexicon Pharmaceuticals.Some support3 reports
-
Novo Nordisk became the licensee for Lexicon's LX9851, and Viatris filed to bring sotagliflozin to markets.Some support2 reports
-
Artal Group S.A. acquired a significant stake in a company, holding 48% of shares, with BlackRock and other investors also involved.Speculative1 report
-
Lexicon Pharmaceuticals is based in The Woodlands, Texas.Some support3 reports
-
Lexicon Pharmaceuticals presented data at a conference in Berlin in September 2025.Some support2 reports
No events began in the chosen period. Widen it, or reset.
Around Lexicon Pharmaceuticals this week
News at the entities that move Lexicon Pharmaceuticals most-
Novo Nordisk StructuralNovo Nordisk and Astellas Pharma are noted as large-cap healthcare companies, with Novo Nordisk reporting higher revenue and earnings.Moves Lexicon Pharmaceuticals
-
FDA StructuralFDA conducted widespread seizures of prohibited food items and products across Pune, Nashik, Mumbai, Konkan, and Nanded.Moves Lexicon Pharmaceuticals
-
Citigroup Mentioned togetherThe repeal of a separation wall in 2009 allowed a merger between Citigroup and Citibank.Moves Lexicon Pharmaceuticals
-
Cantor Fitzgerald Mentioned togetherAgilysys CEO Ramesh Srinivasan sold significant company shares, with the transaction disclosed via filings with the SEC, concurrent with a rating from Cantor Fitzgerald.Moves Lexicon Pharmaceuticals
-
Texas Shared contextThe Texas Hospital Association represents hospitals across the state of Texas.Moves Lexicon Pharmaceuticals
-
New York City Shared contextHavana Rose Liu was spotted walking in a park in New York City.Moves Lexicon Pharmaceuticals
Connections
The 9 strongest of 37, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
Craig Granowitz Structural
Craig Granowitz serves as the Chief Medical Officer and senior vice president of Lexicon Pharmaceuticals.
-
Novo Nordisk Structural
Lexicon Pharmaceuticals granted Novo Nordisk an exclusive license for its obesity drug LX9851, which Novo Nordisk develops and commercializes.
-
FDA Structural
FDA regulates Lexicon Pharmaceuticals' drug development, filing, and trial design processes.
-
Citigroup Mentioned together
Citigroup provides financial ratings and analysis on Lexicon Pharmaceuticals' stock.
-
Rachel Martens Structural
Rachel Martens serves as CCO for Lexicon Pharmaceuticals.
-
Cantor Fitzgerald Mentioned together
Cantor Fitzgerald began providing financial coverage on Lexicon Pharmaceuticals shares.
-
Texas Shared context
Lexicon Pharmaceuticals is based in Texas.
-
Texas Shared context
Lexicon Pharmaceuticals is located in the state of Texas.
Show all 9 connections
-
New York City Shared context
Lexicon Pharmaceuticals is observed operating within the context of New York City, specifically at industry conferences and presentations.
History
Events by the month they beganOctober 2026
1 eventJuly 2026
1 eventJune 2026
6 events- Lexicon Pharmaceuticals partnered with Novo Nordisk on asset LX9851 for optionality.
- Citigroup raised its rating on the stock of Lexicon Pharmaceuticals.
- Novo Nordisk became the licensee for Lexicon's LX9851, and Viatris filed to bring sotagliflozin to markets.
- Artal Group S.A. acquired a significant stake in a company, holding 48% of shares, with BlackRock and other investors also involved.
- Lexicon Pharmaceuticals is based in The Woodlands, Texas.
- Lexicon Pharmaceuticals presented data at a conference in Berlin in September 2025.